The Metabolic Terrain Institute of Health (MTIH) is thrilled to announce the appointment of Dr. Ahmed Elsakka as the Director of Research, bolstering their team and advancing their vision of revolutionizing cancer care and prevention through cutting-edge research, education, advocacy, community building, and healing.
Dr. Elsakka is an esteemed Metabolic Therapies Specialist, Clinician, and Scientist with profound expertise in various research fields, including neurometabolism, ozone therapy, regenerative medicine, photodynamic therapy, sonodynamic therapy, methionine metabolism, ferroptosis, tissue healing, and metabolic management of cancer. Previously serving as the Senior Researcher and Medical Director of The Egyptian Foundation for Research and Community Development, Dr. Elsakka brings a wealth of experience and knowledge to MTIH.
After completing his medical education at the prestigious Faculty of Medicine, Alexandria University, Egypt, and a rigorous 5-year neurosurgery residency, Dr. Elsakka pursued further studies in neuro-metabolism at John Hopkins University in the United States. His deep exploration into cellular energetics, particularly the impact of a ketogenic diet on cancer cell metabolism, piqued his interest in cancer research at submolecular levels. Notably, he also collaborated with Professor Thomas Seyfried, a global leader in Cancer Metabolism study, and they co-authored multiple scientific papers together during his time at Boston College.
Continuing his quest for knowledge, Dr. Elsakka obtained post-graduate diplomas in clinical applied biochemistry from Harvard Medical School, epigenetics and gene expression from Melbourne University in Australia, and clinical nutrition and metabolism from the National Nutritional Institute in Cairo, Egypt. He is associated with prominent organizations, including the Global Society of Metabolic Therapy (co-founder), the Global Leadership Panel at Fight Cancer Global, the Egyptian Functional Medicine Association, and the Egyptian Medical Society for Ozone Therapy and Complementary Medicine. Moreover, his expertise extends to drug delivery systems, nanotechnology, and phytochemical extraction, having collaborated with a compounding pharmaceutical company in Brazil to conduct workshops and train their team.
Dr. Elsakka’s profound knowledge and extensive experience in clinical metabolism, cancer metabolism, and clinical applied biochemistry make him an invaluable asset to the MTIH team. He is enthusiastic about contributing his expertise to support the institute’s development of groundbreaking approaches for the prevention, diagnosis, and treatment of cancer and other complex metabolic diseases.
“I am thrilled to be a part of the Metabolic Terrain Institute of Health,” said Dr. Elsakka. “It is an honor to collaborate with such a dedicated and forward-thinking team. Together, we will translate laboratory discoveries into clinical practice, paving the way for safe and effective therapeutic paradigms that will benefit the medical community and beyond.”
Nasha Winters, ND, FABNO, Executive Director, and Co-founder of the Metabolic Terrain Institute of Health, expressed her excitement about Dr. Elsakka joining the team.
“We are honored to welcome Dr. Ahmed Elsakka to MTIH,” Dr. Winters said. “His vast knowledge and experiences in clinical metabolism and cancer research will undoubtedly contribute to our mission of treating the root cause and symptoms of each person’s unique cancer process. Dr. Elsakka’s expertise will help us develop groundbreaking approaches that will revolutionize cancer treatment.”
About the Metabolic Terrain Institute of Health
The mission of the Metabolic Terrain Institute of Health (MTIH) is to restore health for people with cancer through Research, Education, Advocacy, Community, and Healing (REACH), and we are revolutionizing healthcare by utilizing a metabolic approach to treat cancer and other complex metabolic diseases. Guided by Dr. Nasha Winters’ pioneering “Test, Assess and Address ™” methodology, we prioritize comprehensive testing and assessment to gain deep insights into the metabolic terrain of each patient. This allows us to tailor targeted interventions that directly address the underlying factors contributing to disease progression.
Through our education programs, we are empowering healthcare professionals, patients, and communities with a deep understanding of metabolic processes; through our patient grant programs, we are working to ensure equitable access to resources for cancer patients; and through community, collaboration and interdisciplinary research, we are driving advancements in metabolic therapies, catalyzing positive change in cancer care and healthcare. Our vision is a future where personalized metabolic approaches will be the standard of care – transforming lives, and offering hope and healing on the path to wellness. For more information, visit mtih.org or email email@example.com.